Advanced non-small cell lung cancer in elderly patients: The standard every 3-weeks versus weekly paclitaxel with carboplatin

Background: Paclitaxel and platinum-based chemotherapy is considered to be a standard approach for locally advanced and metastatic non-small cell lung cancer (NSCLC). In recent years, paclitaxel on a weekly schedule in combination with carboplatin has been widely used because it is associated with a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hala Mohamed El-Shenshawy, Saleh Taema, Eman El-Zahaf, Wafaa El-Beshbeshi, Doaa Sharaf Eldeen, Amal Fathy
פורמט: Artigo
שפה:Inglês
יצא לאור: Wolters Kluwer Medknow Publications 2012-10-01
סדרה:Egyptian Journal of Chest Disease and Tuberculosis
נושאים:
Elderly
Non-small cell lung cancer
Paclitaxel
Carboplatin
גישה מקוונת:http://www.sciencedirect.com/science/article/pii/S0422763812000763
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים